Anti-Human DR5 (Drozitumab) Dylight® 488
Produktgrößen
100 µg
£760,00
12-8062-100UG
Über dieses Produkt
- SKU:
- 12-8062
- Zusätzliche Namen:
- DR5; CD262; KILLER; TRICK2; TRICKB; ZTNFR9; TRAILR2; TRICK2A; TRICK2B; TRAIL-R2; KILLER/DR5
- translate.label.attr.clone:
- PRO95780
- Klonalität:
- Monoclonal
- Weitere Details:
- Expression Host : HEK-293 This non-therapeutic biosimilar antibody uses the same variable region sequence as the therapeutic antibody Drozitumab. Clone PRO95780 recognizes human death receptor 5 (DR5). This product is for research use only. Drozitumab is a monoclonal antibody that specifically binds to human DR5. DR5 is expressed in a variety of solid tumors and hematologic malignancies; which are characteristically resistant to apoptosis. Drozitumab is a proapoptotic receptor agonists (PARA) that induces apoptosis in a variety of human cancer cell lines and xenograft models; both alone and in tandem with other antineoplastic agents.1 Apoptosis of cancer cells triggered by the activation of DR5; occurs without affecting most normal cell types. Anti-Human DR5 (Drozitumab) utilizes the same variable regions from the therapeutic antibody Drozitumab making it ideal for research projects.
- Host:
- Human
- Immunogen:
- DR5 scFv
- Isotyp:
- Human IgG1lambda
- Reaktivitäten:
- Human
- Versandbedingungen:
- Blue Ice
- Lagerbedingungen:
- This DyLight® 488 conjugate is stable when stored at 2-8[o]C. Do not freeze.
- Hersteller:
- Abeomics
- Typ:
- Antibodies:Monoclonal Antibody
- Datenblatt des Herstellers:download_pdf.php